Pentara’s clients are primarily small pharmaceutical and biotech companies, but also include academic groups, medium and large pharmaceutical companies. Our projects include phase 1-phase 4 clinical trials. Our phase 1 experience includes single ascending dose (SAD), multiple ascending dose (MAD), pharmacokinetic, bioequivalence, and multi-stage cross-over trials. In phase 2, we provide a strategic balance between cost and sample size by helping our clients reduce error in order to increase the power of the study within a manageable budget. In many cases we can increase the impact of the sample size by 20-30%

Piechart of the percent categories of Pentara's clients